CATEGORIES

Press Release

LATEST

TRENDING

EDITORS CHOICE

FDA Approves Drug Combination for Treating Mesothelioma

First approval in 16 years for mesothelioma, a type of cancer caused by inhaling asbestos fibers SILVER SPRING, Md., Oct. 2, 2020 /PRNewswire/ -- Today, the U.S. Food...

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

FDA grants yet another EUA for RNA Extraction-Free Covid-19 Assay

A SARS-CoV-2 diagnostic test which eliminates the costly and time-consuming step of RNA extraction. As opposed to most other molecular assays that rely on RNA extraction and qRT-PCR

Digital Salutem Welcomes Gil Bashe and Stacy Hurt as Board Members

Digital Salutem is delighted to announce that digital health influencers, Gil Bashe and Stacy Hurt, have joined ours team as board members